Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
125.55(c) 132.2(c) 132.85(c) 135.82(c) 133.2(c) Last
1 351 412 3 073 965 1 119 812 1 672 488 1 234 090 Volume
+0.38% +5.30% +0.49% +2.24% -1.93% Change
More quotes
Financials ($)
Sales 2015 1 064 M
EBIT 2015 -300 M
Net income 2015 -429 M
Finance 2015 565 M
Yield 2015 -
Sales 2016 2 869 M
EBIT 2016 1 230 M
Net income 2016 1 000 M
Finance 2016 1 400 M
Yield 2016 -
PER 2015 -
PER 2016 36,81
EV / Sales 2015 29,8x
EV / Sales 2016 10,8x
Capitalization 32 246 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
04/29Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
04/23 VERTEX PHARMACEUTICALS : Assigned Patent
04/22 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Broaden Under..
04/20 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
04/16 VERTEX PHARMACEUTICALS : Data on Influenza Discussed by Researchers at Vertex Ph..
04/16 VERTEX PHARMACEUTICALS : Patent Issued for Method for Measuring ATR Inhibition M..
04/15 VERTEX PHARMACEUTICALS : to Announce First Quarter 2015 Financial Results on Apr..
04/15 NASDAQ 100 MOVERS : Vrtx, wdc
04/13 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
More news
Sector news : Biopharmaceuticals
10:25a ABBVIE : Presents Late-Breaking, Preliminary Phase 3b Data with VIEKIRAX® + EXVI..
10:15a BRISTOL MYERS SQUIBB : ALLY-1 Trial Results Show Investigational Daclatasvir-Bas..
04:07a MERCK KGAA : Wins German Innovation Award with Liquid Crystals
More sector news : Biopharmaceuticals
News from SeekingAlpha
04/24 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Isn't Perfect, Biogen-Bass, Spring Fever..
04/24 NEXT WEEK IN BIOTECH : Gilead, Celgene Report; PDUFAs For Theravance, The Medici..
04/22 Gilead Buying Vertex? What's The Use?
04/09 WHY INVESTORS SHOULDN'T WORRY ABOUT : Maxim's Jason Kolbert
04/08 Among The Jitters, Big Pharma Laggards Make Up Lost Ground


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF